Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Shares Outstanding (Weighted Average) (2020 - 2025)

Foghorn Therapeutics has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $63.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $63.0 million for Q4 2025, up 14.72% from a year ago — trailing twelve months through Dec 2025 was $63.0 million (up 14.72% YoY), and the annual figure for FY2025 was $63.0 million, up 14.72%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $63.0 million at Foghorn Therapeutics, roughly flat from $63.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for FHTX hit a ceiling of $63.0 million in Q3 2025 and a floor of $36.8 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $41.9 million (2023), compared with a mean of $46.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 614.31% in 2021 and later rose 0.52% in 2023.
  • Foghorn Therapeutics' Shares Outstanding (Weighted Average) stood at $37.2 million in 2021, then rose by 11.89% to $41.6 million in 2022, then increased by 0.92% to $42.0 million in 2023, then soared by 30.79% to $54.9 million in 2024, then rose by 14.72% to $63.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $63.0 million (Q4 2025), $63.0 million (Q3 2025), and $63.0 million (Q2 2025) per Business Quant data.